540937 Stock Overview
Develops, manufactures, and sells pharmaceutical and nutraceutical products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medico Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹46.65 |
| 52 Week High | ₹92.87 |
| 52 Week Low | ₹35.00 |
| Beta | 0.16 |
| 11 Month Change | -4.62% |
| 3 Month Change | 13.78% |
| 1 Year Change | -40.26% |
| 33 Year Change | 56.18% |
| 5 Year Change | 963.25% |
| Change since IPO | 860.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540937 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -17.1% | 0.5% | 0.5% |
| 1Y | -40.3% | 42.5% | 27.5% |
Return vs Industry: 540937 underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 540937 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 540937 volatility | |
|---|---|
| 540937 Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 540937's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 540937's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 193 | Harshit Mehta | medicoremedies.com |
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It exports its products.
Medico Remedies Limited Fundamentals Summary
| 540937 fundamental statistics | |
|---|---|
| Market cap | ₹3.87b |
| Earnings (TTM) | ₹76.77m |
| Revenue (TTM) | ₹1.41b |
50.4x
P/E Ratio2.7x
P/S RatioIs 540937 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540937 income statement (TTM) | |
|---|---|
| Revenue | ₹1.41b |
| Cost of Revenue | ₹1.06b |
| Gross Profit | ₹356.59m |
| Other Expenses | ₹279.82m |
| Earnings | ₹76.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 25.25% |
| Net Profit Margin | 5.44% |
| Debt/Equity Ratio | 18.6% |
How did 540937 perform over the long term?
See historical performance and comparison